Trials / Recruiting
RecruitingNCT07082387
External Oblique and Rectus Abdominis Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy
External Oblique and Rectus Abdominis Plane (EXORA) Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare the effects of the external oblique and rectus abdominis plane (EXORA) block and the quadratus lumborum block (QLB) on postoperative analgesia in patients undergoing laparoscopic cholecystectomy (LC).
Detailed description
Laparoscopic cholecystectomy (LC) is a proven, gold standard surgical procedure for the management of gallbladder stones. The quadratus lumborum block (QLB) is a regional block that would appear to be similar to the posterior TAP block, although the drug injection area is deeper and more dorsal than the transverse abdominal aponeurosis. The external oblique and rectus abdominis plane (EXORA) block is an emerging technique providing a sensory block to the anterolateral abdominal wall.
Conditions
- External Oblique and Rectus Abdominis Plane Block
- Quadratus Lumborum Block
- Postoperative Analgesia
- Laparoscopic Cholecystectomy
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | External oblique and rectus abdominis plane block | Patients will receive an external oblique and rectus abdominis plane (EXORA) block using 20ml of bupivacaine 0.25%. |
| OTHER | Quadratus lumborum block | Patients will receive a quadratus lumborum block (QLB) using 20ml of bupivacaine 0.25%. |
Timeline
- Start date
- 2025-07-24
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2025-07-24
- Last updated
- 2025-07-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07082387. Inclusion in this directory is not an endorsement.